Dr. Marty Makary, Trump’s nominee to lead the FDA, said he would review a Biden-era rule that allowed patients to obtain mifepristone without seeing a health care provider in person.
Dr. Marty Makary, Trump’s nominee to lead the FDA, said he would review a Biden-era rule that allowed patients to obtain mifepristone without seeing a health care provider in person.